NCT03969238

Brief Summary

The investigator propose to develop an opioid telephone helpline, where trained counselors and educators provide referral, educational and targeted interventions and support to individuals interested in addressing their addiction or needing help with managing their pain. The proposed application builds on "tobacco quit line" efforts, a nationally-adopted telephone-based service, providing education materials, access to cessation medication and counseling against tobacco use. Similar to tobacco quit line; the proposed telephone based services will remove barriers to treatment as they help individuals at the exact time of need. The helpline will also educate individuals with new onset pain about pain expectations, relaxation techniques, use of pharmacology and psychotherapy for treatment in addition to providing support for coping and reducing dependency on prescription opioids. It will be a low cost, easily accessible and utilizable technology to augment the clinical outcome of medication assisted treatment of opioid use disorder and pain management.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 31, 2019

Completed
25 days until next milestone

Study Start

First participant enrolled

June 25, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 4, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 4, 2021

Completed
Last Updated

May 27, 2026

Status Verified

May 1, 2026

Enrollment Period

1.9 years

First QC Date

March 27, 2019

Last Update Submit

May 22, 2026

Conditions

Keywords

opioid dependencepain management

Outcome Measures

Primary Outcomes (2)

  • Participant Opioid Helpline Survey

    Primary outcomes measure the rating of the Helpline by the patients. They will be sent surveys that will ask the patients to rate the services they receive on a scale of 1 to 10, with 1 meaning they are very dissatisfied and 10 meaning they are very satisfied.

    up to a year

  • Provider Opioid Helpline Survey

    Primary outcomes measure the rating of the Helpline by the providers. They will be sent surveys that will ask the providers to rate the services they receive on a scale of 1 to 10, with 1 meaning they are very dissatisfied and 10 meaning they are very satisfied.

    up to a year

Secondary Outcomes (5)

  • Number of participants reached versus called.

    up to a year

  • Number of participants who continued to access the services of Helpline

    up to a year

  • New General Self-Efficacy Measure

    up to a year

  • Opioid Helpline Study Screen Form

    up to a year

  • Referral follow-ups

    up to a year

Study Arms (1)

Patients/Providers

Of the1,000 participants: (1) 900 will enroll as participants who use the helpline resources via verbal consent and (2) 100 will enroll as providers via online consent prior to survey data collection.

Behavioral: Helpline

Interventions

HelplineBEHAVIORAL

This helpline will aim to provide patients with new diagnosis of pain who are prescribed opioids, access to education, support and free behavioral technique to help manage their pain such as mindfulness exercises. For those with opioid use disorder, the helpline will offer support in the form of education about the disorder, opioid withdrawal symptoms, risks of overdoses, and a variety of services such as help reach appropriate care with MAT licensed providers, information on FDA-approved MAT and naloxone, and, in some cases, behavioral intervention to keep patients engaged in treatment. The opioid helpline will provide a central resource for direct services and a portal for community services. It will also serve as a referral resource for health-care professionals.

Patients/Providers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We plan to pilot this model in a small rural area with low accessibility to specialized treatment. We will specifically target the area of county of Wise as it is an area with one of the highest rate of opioid addiction and overdose related deaths in the state. UVA hospital: we plan to pilot this model at UVA hospital because it is a health care system offering care to a diverse population from urban and rural areas. The providers will be educated regarding the goals and objectives of the helpline: Any specialty physicians, nurses including dentists that prescribes opioids within Virginia They will be asked to have flyers about the helpline in their office and refer patients who are prescribed opioids to get more support from the helpline.

You may qualify if:

  • Participant Criteria:
  • Age greater than or equal to 18 years.
  • A formal diagnosis of Opioid Use Disorder (OUD) by a health care provider or
  • If no formal diagnosis of OUD, having a self-reported concern with opioid use or addiction.
  • An individual seeking to reduce opioid use.
  • An individual concerned about opioids prescribed for management of new-onset pain or chronic pain.
  • Provider Criteria:
  • University of Virginia: Providers of any specialties within VA including dentists that prescribes opioids.
  • County of Wise: Providers of any specialties including dentists that prescribes opioids.

You may not qualify if:

  • Participant Criteria:
  • Individuals under 18 years of age.
  • Individuals seeking treatment for non-opioid substance use disorders
  • Individuals who have no pain issues
  • Individuals located outside of Virginia.
  • Provider Criteria:
  • Providers outside the designated regions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UVA Center for Leading Edge Addiction Research

Charlottesville, Virginia, 22903, United States

Location

MeSH Terms

Conditions

Opioid-Related DisordersAgnosia

Condition Hierarchy (Ancestors)

Narcotic-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental DisordersPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Nassima Ait-Daoud Tiouririne, M.D.

    University of Virginia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Director of UVA Center for Leading Edge Addiction Research

Study Record Dates

First Submitted

March 27, 2019

First Posted

May 31, 2019

Study Start

June 25, 2019

Primary Completion

May 4, 2021

Study Completion

May 4, 2021

Last Updated

May 27, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations